Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-05-27 @ 11:09 PM
Study NCT ID:
NCT00957060
Status:
COMPLETED
Last Update Posted:
2010-11-30
First Post:
2009-08-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GLIME_L_04140
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Trial Transparency Team
Old Organization:
sanofi-aventis